[BCL-2 inhibitor combined with low dose cytarabine in the treatment of relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review].

Zhang, Y; Tang, J Y; Zhang, M; Zhang, Y; Tian, L P; Wang, Z; Duan, M H

Zhang, Y; Tang, J Y; Zhang, M; Zhang, Y; Tian, L P; Wang, Z; Duan, M H.

Afiliação

Zhang Y; Department of Hematology, Beijing Longfu Hospital, Beijing 100010, China.
Tang JY; Department of Hematology, Beijing Longfu Hospital, Beijing 100010, China.
Zhang M; Department of Hematology, Beijing Longfu Hospital, Beijing 100010, China.
Zhang Y; Department of Hematology, Beijing Longfu Hospital, Beijing 100010, China.
Tian LP; Department of Hematology, Beijing Longfu Hospital, Beijing 100010, China.
Wang Z; Department of Hematology, Beijing Longfu Hospital, Beijing 100010, China.
Duan MH; Department of Hematolog, y Beijing Union Medical College Hospital, Beijing 100730, China.

Zhonghua Xue Ye Xue Za Zhi ; 40(2): 144-146, 2019 Feb 14.

Article em Zh | MEDLINE | ID: mdl-30831631

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: Zh Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: Zh Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China